Certificates of analysis: a challenge to interpret

Abstract : The active pharmaceutical ingredient (API) in a medicinal product is the component that is responsible for the therapeutic effect. The personnel at the ANSES Fougères Laboratory routinely handle medicinal analytical standard and calculate their API content using the certificates of analysis provided by the manufacturer. However, meaningful data in these documents are not always easy to determine or may sometimes be absent: interpretation of these data can therefore result in assessment errors. Having identified this problem, the ANSES Laboratory has put forward an approach aimed at harmonising interpretation of certificates of analysis.
Document type :
Journal articles
Complete list of metadatas

https://hal-anses.archives-ouvertes.fr/anses-01787685
Contributor : Emmanuelle Chiffoleau <>
Submitted on : Monday, May 7, 2018 - 5:04:51 PM
Last modification on : Tuesday, February 19, 2019 - 3:14:07 PM
Long-term archiving on : Tuesday, September 25, 2018 - 3:38:04 PM

File

creff27.pdf
Publisher files allowed on an open archive

Identifiers

Collections

Citation

Catherine Creff-Froger, Mélaine Bessiral, Marie-Pierre Fourmond, Céline Hedou, Agnès Perrin-Guyomard. Certificates of analysis: a challenge to interpret . EuroReference - Les Cahiers de la Référence, ANSES - Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail (France), 2017, pp.27-34. ⟨http://euroreference.mag.anses.fr/sites/default/files/17_12_ED_ER_03-3_CREFF_FROGER.PDF⟩. ⟨10.5281/zenodo.1172022⟩. ⟨anses-01787685⟩

Share

Metrics

Record views

24

Files downloads

12